SVR Cicavit+ DM+ Cicatrices Anti-scarring Silicone Gel 15g

Medical product indicated for treating local and extended scars caused by skin lesions following dermatological treatments or surgery (closed wounds) or second-degree superficial burns (laser, radiotherapy). Adults. Face, body, joints, mobile areas.

What type of scars?

After wound closure and removal of stitches, sutures and strips, if applicable: after the use of sutures (following a fracture, road accident, domestic accident, cosmetic surgery, etc.); after a second-degree superficial burn caused by prolonged contact with a hot or cold substance (water, hot oil, fire, hot plastic, ice, etc.); after a caesarean section; after radiodermatitis; after a thyroidectomy; after ear pinning surgery; after laser tattoo removal; after radiofrequency mole removal; after laser hair removal that was too intensive or too localised, etc.

Every year, more than 100 million(1) patients develop scars, and around 4 million(1) burn scars are caused, 70% on children.

To help people feel comfortable in their skin with scars, SVR has developed its second medical product in compliance with international clinical recommendations: “silicones are recommended as a first line treatment for the initial management of all scars and for the prevention of hypertrophic and keloid scars.”(2)

The formula is highly concentrated in rigorously selected silicones. Its non-greasy, non-sticky gel texture forms a semi-occnlusive, invisible film to provide a barrier protection: - Maintains a humid environment that favours scar healing - Immediately soothes and calms itching - Reduces redness and tightness - Reduces and prevents the formation of red, thick, rigid scars - Flattens and smooths scars - Makes scars less visible

PATIENTS AGREE IT WAS EFFECTIVE! - 100% (3): scars softened - 100% (4): scars less visible - 100% (4): scars smoothed - 100% (5): prevents red and swollen scars

1- Bayat, A., McGrouther, D. A. & Ferguson, M. W. J. Skin scarring. BMJ 326, 88–92 (2003) 2- Mustoe TA et al. Plast reconstructive surg 2002; 110: 560-71 3- Clinical investigation, self-assessment, % agreement, 29 patients over 30 days, twice-daily application of CICAVIT DM+ Cicatrices, groups: burns, radiodermatitis, post-thyroidectomy 4- Clinical investigation, self-assessment, % agreement, 19 patients over 30 days, twice-daily application of CICAVIT DM+ Cicatrices, groups: burns, radiodermatitis 5- Clinical investigation, self-assessment, % agreement, 10 patients over 30 days, twice-daily application of CICAVIT DM+ Cicatrices, group: post-thyroidectomy